Maqui Berry Extract and Omega-3 Fatty Acids for Cytokine Reduction
Trial Summary
What is the purpose of this trial?
This trial tests if a mix of maqui berry extract and omega-3 fatty acids can lower inflammation in older, obese adults. Maqui berries have special plant pigments that reduce inflammation, and omega-3s are known for their anti-inflammatory effects. Maqui berries (Aristotelia chilensis) are known for their antioxidant, anticancer, and anti-inflammatory properties.
Will I have to stop taking my current medications?
Yes, you will need to stop taking certain medications, such as blood thinners, anti-inflammatory drugs, cardiovascular medications, lipid-altering drugs, and hormone replacement therapy, to participate in this trial.
What data supports the effectiveness of the treatment Maqui berry/omega-3 fatty acids?
Is the treatment with omega-3 fatty acids safe for humans?
How does the Maqui berry/omega-3 fatty acids treatment differ from other treatments?
This treatment is unique because it combines Maqui berry, known for its antioxidant properties, with omega-3 fatty acids, which have anti-inflammatory effects. This combination may offer a novel approach to reducing inflammation and oxidative stress, which are not typically addressed together in standard treatments.1381011
Eligibility Criteria
Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive maqui berry extract and omega-3 fatty acids or placebo for cytokine reduction
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Maqui berry/omega-3 fatty acids
- Placebos
Find a Clinic Near You
Who Is Running the Clinical Trial?
Arizona State University
Lead Sponsor